Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Deloitte
Express Scripts
Julphar
Colorcon
QuintilesIMS

Generated: August 17, 2019

DrugPatentWatch Database Preview

Claims for Patent: 5,147,641

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,147,641
Title: Microcapsule for the removal of specific amino acids through the entero-portal recirculation
Abstract:A microcapsule for oral administration comprising an outer layer membrane which is acid resistant and retains its structure in an alkaline environment, said membrane having dispersed therein at least one enzyme corresponding to an amino acid secreted into the intestinal or derived from a protein or peptide secreted into the intestinal tract. The present invention provides a microcapsule capable of removing specific unwanted amino acids secreted into the intestinal tract.
Inventor(s): Chang; Thomas M. S. (St-Lambert, CA), Bourget; Louis (Pierrefonds, CA), Lister; Colin (Brossard, CA)
Assignee: The Royal Institution for the Advancement of Learning (McGill University) (Quebec, CA)
Application Number:07/719,110
Patent Claims:1. A method for decreasing the reabsorption of at least one undesirable endogenous amino acid selected from only the amino acids secreted directly into the intestinal tract from the enteroportal recirculation system of the human body, which comprises orally administering microcapsules consisting of an outer-layer membrane which is acid resistant and retains its structure in an alkaline environment, said membrane encapsulating at least one enzyme capable of degrading said undesirable amino acid present in the intestinal tract or derived from a protein or peptide secreted into the intestinal tract wherein said undesirable amino acid in the intestinal tract will diffuse into said microcapsules where said amino acid is subjected to a partial or complete degradation by the encapsulated enzyme and the degradation products are then secreted from said microcapsules into the intestinal tract and said microcapsules are naturally excreted from the intestinal tract.

2. The method of claim 1, wherein the enzyme is asparaginase and the secreted amino acid is asparagine.

3. The method of claim 1, wherein the enzyme is tyrosinase and the secreted amino acid is tyrosine.

4. The method of claim 1, wherein the enzyme is glutaminase and the secreted amino acid is glutamine.

5. The method of claim 1, wherein the enzyme is histidinase and the secreted amino acid is histidine.

6. The method of claim 1, wherein the enzyme is tryptophanase and the secreted amino acid is tryptophan.

7. The method of claim 1, wherein the enzyme is phenylalanine ammonialyase and the secreted amino acid is valine.

8. The method of claim 1, wherein the enzyme is arginase and the secreted amino acid is arginine.

9. The method of claim 1, wherein the enzyme is lysine decarboxylase and the secreted amino acid is lysine.

10. The method of claim 1, wherein the enzyme is methionine racemase and the secreted amino acid is methionine.

11. The method of claim 1, wherein the enzyme is cystine desulphydrase and the secreted amino acid is cystine.

12. The method of claim 1, wherein the enzyme is a deaminase and the secreted amino acid is proline.

Details for Patent 5,147,641

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial The Royal Institution for the Advancement of Learning (McGill University) (Quebec, CA) 2036-04-30 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
AstraZeneca
US Department of Justice
Cipla
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.